The FDA on Monoclonal Antibody Therapeutics: What physicians need to know, Part I

AMA Update

English - February 11, 2022 11:00 - 10 minutes - 9.22 MB - ★★★★ - 55 ratings
Medicine Health & Fitness Science Life Sciences ama covid covid symptoms cdc covid-19 kids getting vaccinated pfizer vaccination fda medical experts Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Andrea Garcia, JD, MPH, shares new CDC data on detecting COVID surges in advance

Next Episode: Sandra Fryhofer, MD, on what new FDA licensing & authorization requests mean for patients

AMA president Gerald Harmon, MD, welcomes experts from the U.S. Food and Drug Administration (FDA) to discuss what prescribers need to know about COVID-19 therapeutic drugs, Paxlovid and Molnupiravir. Alternative treatment options for high-risk outpatients with mild-moderate COVID-19 are also discussed.

Guest: John Farley, MD, MPH, director, Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA